Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04758689
Other study ID # REC/002-2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 20, 2020
Est. completion date December 22, 2020

Study information

Verified date May 2021
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Studying the effect of laser acupuncture on geriatric patients with rheumatoid arthritis


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 22, 2020
Est. primary completion date December 20, 2020
Accepts healthy volunteers No
Gender All
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria: - Patients referred from physician (immunologist) diagnosed with rheumatoid arthritis. Exclusion Criteria: - Patients having the disease overlapping with other connective tissue diseases, such as systematic lupus erythromatosus and systematic sclerosis. - History of malignancies.

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Laser, exercise, and methotrexate
Laser therapy at acupuncture points, aerobic exercise, and methotrexate
Exercise, and methotrexate
Aerobic exercise, and methotrexate

Locations

Country Name City State
Egypt A. Sedky Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Interleukin 6 (IL-6) interleukin 6 Baseline
Primary Interleukin 6 (IL-6) interleukin 6 4 weeks
Primary Malondialdehyde (MDA) malondialdehyde Baseline
Primary Malondialdehyde (MDA) malondialdehyde 4 weeks
Primary Adenosine Triphosphate (ATP) adenosine triphosphate Baseline
Primary Adenosine Triphosphate (ATP) adenosine triphosphate 4 weeks
Primary C-Reactive Protein (CRP) C-reactive protein Baseline
Primary C-Reactive Protein (CRP) C-reactive protein 4 weeks
Secondary Rheumatoid Arthritis Quality of Life (RAQoL) rheumatoid arthritis quality of life Baseline
Secondary Rheumatoid Arthritis Quality of Life (RAQoL) rheumatoid arthritis quality of life 4 weeks
Secondary Health Assessment Questionnaire (HAQ) health assessment questionnaire Baseline
Secondary Health Assessment Questionnaire (HAQ) health assessment questionnaire 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4